Security key
M96088105
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)
CUSIP: M96088105
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Shares outstanding
- 48,684,257
- Total 13F shares
- 27,162,024
- Share change
- +5,657,717
- Total reported value
- $407,381,837
- Put/Call ratio
- 94%
- Price per share
- $15.00
- Number of holders
- 111
- Value change
- +$84,866,378
- Number of buys
- 48
- Number of sells
- 49
Report period
Q1 2024
Institutions
111
Top holders
10
URGN full security history
Newer quarter: Q2 2024
Previous quarter: Q4 2023
UroGen Pharma Ltd. SEC filings
UroGen Pharma Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M96088105
Recent filing periods:
Top shareholders of URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
6.3%
|
3,083,430
|
$46,251,450 | — | 31 Dec 2023 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
5.4%
|
2,620,545
|
$39,308,175 | — | 31 Dec 2023 | |
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
|
Company |
4.7%
|
2,303,031
|
$34,545,465 | — | 31 Dec 2023 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
3.5%
|
1,726,808
|
$25,902,120 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
3.5%
|
1,719,304
|
$25,789,560 | — | 31 Dec 2023 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
2.5%
|
1,200,000
|
$18,000,000 | — | 31 Dec 2023 | |
| Harel Insurance Investments & Financial Services Ltd. |
13F
|
Company |
1.8%
|
870,045
|
$13,051,000 | — | 31 Dec 2023 | |
| Migdal Insurance & Financial Holdings Ltd. |
13F
|
Company |
1.3%
|
648,302
|
$9,725,000 | — | 31 Dec 2023 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
525,404
|
$7,881,060 | — | 31 Dec 2023 | |
| Wildcat Capital Management, LLC |
13F
|
Company |
1%
|
495,606
|
$7,434,090 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
1%
|
490,831
|
$7,362,465 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.93%
|
455,124
|
$6,826,860 | — | 31 Dec 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.88%
|
426,506
|
$6,397,590 | — | 31 Dec 2023 | |
| Opaleye Management Inc. |
13F
|
Company |
0.66%
|
320,000
|
$4,800,000 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.64%
|
312,516
|
$4,687,740 | — | 31 Dec 2023 | |
| SUPERSTRING CAPITAL MANAGEMENT LP |
13F
|
Company |
0.52%
|
255,430
|
$3,831,450 | — | 31 Dec 2023 | |
| Laurion Capital Management LP |
13F
|
Company |
0.51%
|
250,600
|
$3,759,000 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.48%
|
235,236
|
$3,528,540 | — | 31 Dec 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.45%
|
219,081
|
$3,286,200 | — | 31 Dec 2023 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
0.36%
|
175,500
|
$2,632,500 | — | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.35%
|
170,599
|
$2,558,985 | — | 31 Dec 2023 | |
| ARK Investment Management LLC |
13F
|
Company |
0.33%
|
161,525
|
$2,422,875 | — | 31 Dec 2023 | |
| AlphaCentric Advisors LLC |
13F
|
Company |
0.32%
|
155,000
|
$2,325,000 | — | 31 Dec 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.3%
|
143,879
|
$2,158,185 | — | 31 Dec 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.27%
|
131,900
|
$1,978,500 | — | 31 Dec 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.27%
|
130,755
|
$1,961,325 | — | 31 Dec 2023 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.26%
|
126,000
|
$1,890,000 | — | 31 Dec 2023 | |
| Cerity Partners LLC |
13F
|
Company |
0.26%
|
125,226
|
$1,878,390 | — | 31 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.23%
|
114,221
|
$1,713,315 | — | 31 Dec 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.21%
|
104,600
|
$1,569,000 | — | 31 Dec 2023 | |
| MEITAV INVESTMENT HOUSE LTD |
13F
|
Company |
0.19%
|
91,456
|
$1,371,791 | — | 31 Dec 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.19%
|
91,300
|
$1,370,000 | — | 31 Dec 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.17%
|
83,419
|
$1,251,285 | — | 31 Dec 2023 | |
| Annandale Capital, LLC |
13F
|
Company |
0.17%
|
81,831
|
$1,227,000 | — | 31 Dec 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.16%
|
77,873
|
$1,168,095 | — | 31 Dec 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.15%
|
72,961
|
$1,094,415 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.15%
|
71,664
|
$1,074,960 | — | 31 Dec 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.14%
|
70,104
|
$1,051,560 | — | 31 Dec 2023 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.14%
|
69,892
|
$1,048,380 | — | 31 Dec 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.13%
|
62,880
|
$943,200 | — | 31 Dec 2023 | |
| Atom Investors LP |
13F
|
Company |
0.12%
|
60,165
|
$902,475 | — | 31 Dec 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.12%
|
59,690
|
$895,350 | — | 31 Dec 2023 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.09%
|
45,977
|
$689,655 | — | 31 Dec 2023 | |
| Coastal Bridge Advisors, LLC |
13F
|
Company |
0.08%
|
37,750
|
$566,250 | — | 31 Dec 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
37,367
|
$560,505 | — | 31 Dec 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.07%
|
34,706
|
$520,590 | — | 31 Dec 2023 | |
| BENDER ROBERT & ASSOCIATES |
13F
|
Company |
0.07%
|
34,701
|
$520,515 | — | 31 Dec 2023 | |
| Jump Financial, LLC |
13F
|
Company |
0.07%
|
33,320
|
$499,800 | — | 31 Dec 2023 | |
| SHIKIAR ASSET MANAGEMENT INC |
13F
|
Company |
0.07%
|
33,250
|
$499,000 | — | 31 Dec 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.06%
|
28,552
|
$428,280 | — | 31 Dec 2023 |
Institutional Holders of UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) as of Q1 2024
As of 31 Mar 2024,
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,162,024 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, RA CAPITAL MANAGEMENT, L.P., GREAT POINT PARTNERS LLC, MENORA MIVTACHIM HOLDINGS LTD., BlackRock Inc., COWEN AND COMPANY, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., CREDIT SUISSE AG/, Point72 Asset Management, L.P., and Jefferies Financial Group Inc..
This page lists
111
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
103
Q1 2024 holders
111
Holder diff
8
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.